Market revenue in 2023 | USD 2,576.4 million |
Market revenue in 2030 | USD 4,637.7 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.83% in 2023. Horizon Databook has segmented the U.S. intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the leading market for intravenous infusion pumps in North America. This can be attributed to the country’s high prevalence of cancer, diabetes, and other chronic diseases. According to the American Cancer Society, nearly 140,690 cancer cases were diagnosed in 2019, with a projected 1,806,590 new cases in 2020.
The prevalence of diabetes in the U.S is also quite significant, which can be attributed to negative lifestyle choices and stressful work environment. According to the CDC, 34.2 million Americans were diagnosed with diabetes in 2018, and the number is expected to increase in the future.
There has seen a constant surge in the prevalence of cardiovascular and chronic respiratory diseases in the U.S. Factors such as growing geriatric population and increasing volume of surgical procedures performed are expected to propel the country’s demand for intravenous infusion pumps in the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into U.S. intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account